XUERONG

Zhitong · Oct 15, 2025 at 06:49 AM

XUERONG released its performance for the first three quarters, with a net loss of 62.3484 million yuan

Zhitong · Sep 10, 2025 at 01:37 AM

Guosheng Securities: The production capacity of enoki mushrooms returns rationally, and the profitability of button mushrooms continues

Zhitong · Sep 3, 2025 at 06:07 AM

XUERONG: The shareholding ratio of the controlling shareholder and its concerted actors has decreased to 20.8842%

Zhitong · Jul 24, 2025 at 08:32 PM

The China Securities Convertible Bond Index opened up 0.02%, Guanghe Convertible Bond rose 30% on its first day of listing, Sanyang Convertible Bond increased by 3.9%, and XUERONG Convertible Bond, Fuli Convertible Bond, and Emergency Convertible Bond rose over 1%; Honghui Convertible Bond fell over 2%, while Yaoji Convertible Bond and Sheyan Convertible Bond dropped over 1%

Zhitong · Jun 23, 2025 at 08:29 PM

The China Securities Convertible Bond Index opened up 0.03%. Yong'an Convertible Bond rose by 9.6%, Huafeng Convertible Bond rose by 3.6%, and Lianchuang Convertible Bond, XUERONG Convertible Bond, Quanfeng Convertible Bond, and Hengshuai Convertible Bond rose by more than 2%; Shouhua Convertible Bond fell by 4.7%, and Tianhao Convertible Bond and Chuanheng Convertible Bond fell by more than 2%

Zhitong · May 28, 2025 at 08:37 PM

The cellular immunotherapy sector has seen a short-term surge, with Staidson BioPharm rising over 10%